Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/13/2014US20140073555 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
03/13/2014US20140073005 Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function
03/13/2014US20140072647 Use of vanadium compounds for maintaining normaglycemia in a mammal
03/13/2014US20140072646 Thyroid hormone analogs and methods of use
03/13/2014US20140072637 Treatment for bone formation disorders by growth factor delivery
03/13/2014US20140072621 Composition and method to improve intestinal health
03/13/2014US20140072614 Rapidly acting dry sealant and methods for use and manufacture
03/13/2014US20140072613 Compositions and Methods for Treating Cutaneous Scarring
03/13/2014US20140072612 Rolled collagen carrier
03/13/2014US20140072601 Transport of cells in hydrogels
03/13/2014US20140072600 Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
03/13/2014US20140072588 Absorption of therapeutic agents across mucosal membranes or the skin
03/13/2014US20140072574 Methods of using immunomodulating peptide for treating or preventing inflammatory related diseases
03/13/2014US20140072564 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
03/13/2014US20140072558 Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain
03/13/2014US20140072557 Medicinal agent for suppressing malignant tumor metastasis
03/13/2014US20140072549 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
03/13/2014US20140072548 Production and purification of recombinant arylsulftase
03/13/2014US20140072540 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
03/13/2014US20140072530 Treatment of hiv
03/13/2014US20140072527 Composition for treating intraventricular hemorrhage in preterm infants comprising mesenchymal stem cells
03/13/2014US20140072520 Composition for external preparation for skin
03/13/2014US20140072511 Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
03/13/2014DE112011105133T5 Octapeptid zur Herstellung von radiopharmazeutischen Mitteln, das auf dessen Basis hergestellte Arzneimittel und Diagnoseverfahren von Somatostatin-Rezeptor exprimierenden Tumoren Octapeptide for the preparation of radiopharmaceutical agents, on the basis of the produced medicinal products and diagnostic methods of somatostatin receptor-expressing tumors
03/12/2014EP2706122A2 Isomerases, nucleic acids encoding them and methods for making and using them
03/12/2014EP2706116A1 Binding domain-immunoglobulin fusion proteins
03/12/2014EP2706113A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
03/12/2014EP2706067A1 Probiotic bacteria as carrier for a helminth-derived immunomodulator for the treatment of inflammatory disorders
03/12/2014EP2705851A1 Anti-allergy substance, anti-allergy agent, and food
03/12/2014EP2705850A2 Super fast-acting insulin compositions
03/12/2014EP2705849A2 A preparation for use of aspartate for regulating glucose levels in blood
03/12/2014EP2705844A1 Nutritional composition
03/12/2014EP2705835A1 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
03/12/2014EP2705049A1 Hepatitis c virus inhibitors
03/12/2014EP2704746A2 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
03/12/2014EP2704741A1 Methods for handling biological drugs containing living cells
03/12/2014EP2704738A1 Compositions and methods for treating diabetes
03/12/2014EP2704737A2 Therapeutic nuclease compositions and methods
03/12/2014EP2704736A2 Methods and compositions for targeting adipose cells in mammals
03/12/2014EP2704735A1 Vascular disruption agents and uses thereof
03/12/2014EP2704732A2 Induction of il-12 using immunotherapy
03/12/2014EP2704728A1 Expression signatures of genes and gene networks associated with skin aging
03/12/2014EP2704695A1 Excipient compatibility with ezatiostat
03/12/2014EP2704688A1 Cochleate compositions and methods of making and using same
03/12/2014CN103635570A Recombinant yeast expressing human H-ferritin
03/12/2014CN103635490A Soluble proteins for use as therapeutics
03/12/2014CN103635485A Solid oxidized glutathione salt and method for producing same
03/12/2014CN103635206A Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
03/12/2014CN103635204A CETP fragments
03/12/2014CN103635203A Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
03/12/2014CN103635202A Hemostatic compositions
03/12/2014CN103635201A Variants of human GDNF
03/12/2014CN103635188A Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
03/12/2014CN103635180A Method for producing endoplasmic reticulum
03/12/2014CN103630646A Method for detecting tortoise-derived ingredients in glue type traditional Chinese medicines and products thereof
03/12/2014CN103627785A Biomarker DACT1 for gastric cancer
03/12/2014CN103627760A Method for preparing biological active peptide with effect of reducing trioxypurine by using walnut protein
03/12/2014CN103627690A Mutants of streptokinase and their covalently modified forms
03/12/2014CN103626866A Pancreatic polypeptide family motifs, polypeptides comprising the same and method
03/12/2014CN103626865A Secreted protein with chemotactic activity, as well as coding sequence and medicament usage thereof
03/12/2014CN103626863A Oligopeptide capable of inhibiting growth of cancer cells and encoding gene thereof
03/12/2014CN103626845A Arylpyrrole-2-formamide dipeptide derivatives serving as glycogen phosphorylase inhibitor and preparation method and medical application thereof
03/12/2014CN103626844A Artificial synthetic wheat germ peptide and preparation method and application thereof
03/12/2014CN103626837A Glycogen phosphorylase inhibitor cholic acid derivative containing bio-cleavable dipeptide and preparation method and medical application thereof
03/12/2014CN103623415A PLGA and ethyl alcohol compound used for biological polypeptide preparation
03/12/2014CN103623408A Low dose methods for treating disorders in which tnf dollar g(a) activity is detrimental
03/12/2014CN103623396A Pharmaceutical composition containing recombinant tissue plasminogen activator
03/12/2014CN103623395A Preparation method of high-entrapment rate and stable-drug release polylactic acid lysozyme drug microspheres
03/12/2014CN103623394A Application of PEG-HM-3 and platinum, taxol or Emtriva medicines to preparation of solid tumor medicines
03/12/2014CN103623393A Effects of galectin-9 on systemic lupus erythematosus or similar inflammatory diseases
03/12/2014CN103623392A Antitumour combinations containing a vegf inhibiting agent and irinotecan
03/12/2014CN103623391A Application of antimicrobial peptide Protegrin-1 for preventing and controlling porcine reproductive and respiratory syndrome
03/12/2014CN103623390A Glutamine for use in treating injury
03/12/2014CN103622928A Preparation method and application of pectin-base carrier material
03/12/2014CN103622913A Tetracosactide lipidosome and preparation method thereof
03/12/2014CN103622902A A temperature-sensitive gel medicine preparation and a preparation method thereof
03/12/2014CN103249428B Use of regulator of calcineurin 1 for manufacturing medicament for treatment of diseases associated with increased NF-Kappa B activity
03/12/2014CN103145803B Polypeptide in specific binding with breast cancer brain metastases cells
03/12/2014CN103071148B Compound thymosin Alpha 1 injection for improving livability of piglet and preparation method
03/12/2014CN103041367B Traditional Chinese medicine compound preparation for preventing and treating vaginitis and preparation method thereof
03/12/2014CN103012552B Bioactive polypeptide QEPV, and preparation and application thereof
03/12/2014CN102940881B Ointment for treating skin scalds
03/12/2014CN102871985B Hemoglobin microcapsule blood substitute and its preparation method
03/12/2014CN102836420B Methods and compositions involving MDA-7
03/12/2014CN102775474B Polypeptide and applications thereof
03/12/2014CN102757938B Application of VSTM1 protein in preparation of product for promoting differentiation of leukemic cells
03/12/2014CN102741272B Peptides inhibiting adhesion of aspergillus fumigatus to cornea
03/12/2014CN102731632B Recombinant ganoderma immunomodulatory protein monomethoxypolyglycol succinimidyl propionate modifier, preparation method and use thereof
03/12/2014CN102727468B Dry powder inhaler of interferon alpha
03/12/2014CN102727467B Dry powder inhalant of interferon alpha
03/12/2014CN102671187B Application of LECT2 protein in preparation of antiviral drugs
03/12/2014CN102665754B Immunomodulating polypeptides derived from IL-2 and use thereof in cancer and chronic infections
03/12/2014CN102559636B Antibody fusion protein used for leukemia and autoimmune disease and preparation method thereof
03/12/2014CN102477093B Preparation method of thermal-stable human keratinocyte growth factor mutant and application of preparation method
03/12/2014CN102443548B Method for producing gamma-carboxylated proteins
03/12/2014CN102311957B Hydatidovis soluble antigen preparation method and product thereof
03/12/2014CN102229650B High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/12/2014CN102151337B Compositions and methods for regulated protein expression in gut
03/12/2014CN102112146B Immunity inducer
03/12/2014CN102085377B Immunogenic composition and methods
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 3163